ema glp-1 vision loss recommendation ophthalmology november 2025 GLP-1s for Weight May Lower Risk of Age-Related Macular Degeneration 13 Investigates | Indiana woman

We are aware of no breakthrough or accelerated regulatory designation for a neurodegenerative indication in this class, and the recent Phase 3 failures are likely to make near-term regulatory filings in this space unlikely

However, it is important to note that there is no robust clinical evidence demonstrating that adding L-carnitine to Mounjaro therapy provides additional benefits beyond what Mounjaro achieves alone

Neural tube defects It is known that folate is critical for normal embryonic development, and maternal supplementation with folic acid decreases the incidence of neural tube defects (NTDs) (56)

We understand the confusion surrounding which method delivers better results for your specific health goals and budget